TY - JOUR AU - Nordestgaard, B. G. AU - Chapman, M. J. AU - Humphries, S. E. AU - Ginsberg, H. N. AU - Masana, L. AU - Descamps, O. S. AU - Wiklund, O. AU - Hegele, R. A. AU - Raal, F. J. AU - Defesche, J. C. PY - 2013 DA - 2013// TI - Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society JO - Eur Heart J VL - 34 UR - https://doi.org/10.1093/eurheartj/eht273 DO - 10.1093/eurheartj/eht273 ID - Nordestgaard2013 ER - TY - JOUR AU - Reiner, Z. AU - Simental-Mendia, L. E. AU - Ruscica, M. AU - Katsiki, N. AU - Banach, M. AU - Rasadi, K. AU - Jamialahmadi, T. AU - Sahebkar, A. PY - 2019 DA - 2019// TI - Pulse wave velocity as a measure of arterial stiffness in patients with familial hypercholesterolemia: a systematic review and meta-analysis JO - Arch Med Sci VL - 15 UR - https://doi.org/10.5114/aoms.2019.89450 DO - 10.5114/aoms.2019.89450 ID - Reiner2019 ER - TY - JOUR AU - Miname, M. H. AU - Santos, R. D. PY - 2019 DA - 2019// TI - Reducing cardiovascular risk in patients with familial hypercholesterolemia: risk prediction and lipid management JO - Prog Cardiovasc Dis VL - 62 UR - https://doi.org/10.1016/j.pcad.2019.10.003 DO - 10.1016/j.pcad.2019.10.003 ID - Miname2019 ER - TY - JOUR AU - Dyrbus, K. AU - Gasior, M. AU - Desperak, P. AU - Osadnik, T. AU - Nowak, J. AU - Banach, M. PY - 2019 DA - 2019// TI - The prevalence and management of familial hypercholesterolemia in patients with acute coronary syndrome in the Polish tertiary centre: results from the TERCET registry with 19,781 individuals JO - Atherosclerosis VL - 288 UR - https://doi.org/10.1016/j.atherosclerosis.2019.06.899 DO - 10.1016/j.atherosclerosis.2019.06.899 ID - Dyrbus2019 ER - TY - JOUR AU - Bhagat, U. AU - Das, U. N. PY - 2015 DA - 2015// TI - Potential role of dietary lipids in the prophylaxis of some clinical conditions JO - Arch Med Sci VL - 11 UR - https://doi.org/10.5114/aoms.2015.53302 DO - 10.5114/aoms.2015.53302 ID - Bhagat2015 ER - TY - JOUR AU - Das, U. N. PY - 2008 DA - 2008// TI - Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules JO - Lipids Health Dis VL - 7 UR - https://doi.org/10.1186/1476-511X-7-37 DO - 10.1186/1476-511X-7-37 ID - Das2008 ER - TY - JOUR AU - Raal, F. J. AU - Hovingh, G. K. AU - Catapano, A. L. PY - 2018 DA - 2018// TI - Familial hypercholesterolemia treatments: guidelines and new therapies JO - Atherosclerosis VL - 277 UR - https://doi.org/10.1016/j.atherosclerosis.2018.06.859 DO - 10.1016/j.atherosclerosis.2018.06.859 ID - Raal2018 ER - TY - JOUR AU - Ito, M. K. AU - Watts, G. F. PY - 2015 DA - 2015// TI - Challenges in the diagnosis and treatment of homozygous familial hypercholesterolemia JO - Drugs VL - 75 UR - https://doi.org/10.1007/s40265-015-0466-y DO - 10.1007/s40265-015-0466-y ID - Ito2015 ER - TY - JOUR AU - Friedewald, W. T. AU - Levy, R. I. AU - Fredrickson, D. S. PY - 1972 DA - 1972// TI - Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge JO - Clin Chem VL - 18 UR - https://doi.org/10.1093/clinchem/18.6.499 DO - 10.1093/clinchem/18.6.499 ID - Friedewald1972 ER - TY - JOUR AU - DeLong, D. M. AU - DeLong, E. R. AU - Wood, P. D. AU - Lippel, K. AU - Rifkind, B. M. PY - 1986 DA - 1986// TI - A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol. The lipid research clinics prevalence study JO - JAMA VL - 256 UR - https://doi.org/10.1001/jama.1986.03380170088024 DO - 10.1001/jama.1986.03380170088024 ID - DeLong1986 ER - TY - JOUR AU - Martin, S. S. AU - Blaha, M. J. AU - Elshazly, M. B. AU - Toth, P. P. AU - Kwiterovich, P. O. AU - Blumenthal, R. S. AU - Jones, S. R. PY - 2013 DA - 2013// TI - Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile JO - JAMA VL - 310 UR - https://doi.org/10.1001/jama.2013.280532 DO - 10.1001/jama.2013.280532 ID - Martin2013 ER - TY - JOUR AU - Yeang, C. AU - Witztum, J. L. AU - Tsimikas, S. PY - 2015 DA - 2015// TI - ‘LDL-C’ = LDL-C + Lp(a)-C: implications of achieved ultra-low LDL-C levels in the proprotein convertase subtilisin/kexin type 9 era of potent LDL-C lowering JO - Curr Opin Lipidol VL - 26 UR - https://doi.org/10.1097/MOL.0000000000000171 DO - 10.1097/MOL.0000000000000171 ID - Yeang2015 ER - TY - JOUR AU - Kinpara, K. AU - Okada, H. AU - Yoneyama, A. AU - Okubo, M. AU - Murase, T. PY - 2011 DA - 2011// TI - Lipoprotein(a)-cholesterol: a significant component of serum cholesterol JO - Clin Chim Acta VL - 412 UR - https://doi.org/10.1016/j.cca.2011.05.036 DO - 10.1016/j.cca.2011.05.036 ID - Kinpara2011 ER - TY - JOUR AU - Marcovina, S. M. AU - Albers, J. J. AU - Scanu, A. M. AU - Kennedy, H. AU - Giaculli, F. AU - Berg, K. AU - Couderc, R. AU - Dati, F. AU - Rifai, N. AU - Sakurabayashi, I. PY - 2000 DA - 2000// TI - Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a) JO - Clin Chem VL - 46 UR - https://doi.org/10.1093/clinchem/46.12.1956 DO - 10.1093/clinchem/46.12.1956 ID - Marcovina2000 ER - TY - JOUR AU - Viney, N. J. AU - Yeang, C. AU - Yang, X. AU - Xia, S. AU - Witztum, J. L. AU - Tsimikas, S. PY - 2018 DA - 2018// TI - Relationship between “LDL-C”, estimated true LDL-C, apolipoprotein B-100, and PCSK9 levels following lipoprotein(a) lowering with an antisense oligonucleotide JO - J Clin Lipidol VL - 12 UR - https://doi.org/10.1016/j.jacl.2018.02.014 DO - 10.1016/j.jacl.2018.02.014 ID - Viney2018 ER - TY - JOUR AU - Gaubatz, J. W. AU - Heideman, C. AU - Gotto, A. M. AU - Morrisett, J. D. AU - Dahlen, G. H. PY - 1983 DA - 1983// TI - Human plasma lipoprotein [a]. Structural properties JO - J Biol Chem VL - 258 ID - Gaubatz1983 ER - TY - JOUR AU - Faghihnia, N. AU - Tsimikas, S. AU - Miller, E. R. AU - Witztum, J. L. AU - Krauss, R. M. PY - 2010 DA - 2010// TI - Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate diet JO - J Lipid Res VL - 51 UR - https://doi.org/10.1194/jlr.M005769 DO - 10.1194/jlr.M005769 ID - Faghihnia2010 ER - TY - CHAP AU - Dahlen, G. H. ED - Scanu, A. M. PY - 1990 DA - 1990// TI - Incidence of Lp(a) among populations BT - Lipoprotein(a) PB - Academic Press CY - New York ID - Dahlen1990 ER - TY - JOUR AU - Mach, F. AU - Baigent, C. AU - Catapano, A. L. AU - Koskinas, K. C. AU - Casula, M. AU - Badimon, L. AU - Chapman, M. J. AU - Backer, G. G. AU - Delgado, V. AU - Ference, B. A. PY - 2020 DA - 2020// TI - 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk JO - Eur Heart J VL - 41 UR - https://doi.org/10.1093/eurheartj/ehz455 DO - 10.1093/eurheartj/ehz455 ID - Mach2020 ER - TY - JOUR AU - Rizos, C. V. AU - Athyros, V. AU - Bilianou, E. AU - Chrousos, G. AU - Garoufi, A. AU - Kolovou, G. AU - Kotsis, V. AU - Rallidis, L. AU - Skalidis, E. AU - Skoumas, I. PY - 2017 DA - 2017// TI - An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH) JO - Hormones (Athens) VL - 16 UR - https://doi.org/10.1007/BF03401525 DO - 10.1007/BF03401525 ID - Rizos2017 ER - TY - JOUR AU - Rizos, C. V. AU - Elisaf, M. S. AU - Skoumas, I. AU - Tziomalos, K. AU - Kotsis, V. AU - Rallidis, L. AU - Garoufi, A. AU - Athyros, V. G. AU - Skalidis, E. AU - Kolovou, G. PY - 2018 DA - 2018// TI - Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH) JO - Atherosclerosis VL - 277 UR - https://doi.org/10.1016/j.atherosclerosis.2018.08.017 DO - 10.1016/j.atherosclerosis.2018.08.017 ID - Rizos2018 ER - TY - JOUR AU - Civeira, F. AU - Ros, E. AU - Jarauta, E. AU - Plana, N. AU - Zambon, D. AU - Puzo, J. AU - Martinez de Esteban, J. P. AU - Ferrando, J. AU - Zabala, S. AU - Almagro, F. PY - 2008 DA - 2008// TI - Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia JO - Am J Cardiol VL - 102 UR - https://doi.org/10.1016/j.amjcard.2008.06.056 DO - 10.1016/j.amjcard.2008.06.056 ID - Civeira2008 ER - TY - JOUR AU - Goldberg, A. C. AU - Hopkins, P. N. AU - Toth, P. P. AU - Ballantyne, C. M. AU - Rader, D. J. AU - Robinson, J. G. AU - Daniels, S. R. AU - Gidding, S. S. AU - Ferranti, S. D. AU - Ito, M. K. PY - 2011 DA - 2011// TI - Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia JO - J Clin Lipidol VL - 5 UR - https://doi.org/10.1016/j.jacl.2011.04.003 DO - 10.1016/j.jacl.2011.04.003 ID - Goldberg2011 ER - TY - JOUR AU - Wiegman, A. AU - Gidding, S. S. AU - Watts, G. F. AU - Chapman, M. J. AU - Ginsberg, H. N. AU - Cuchel, M. AU - Ose, L. AU - Averna, M. AU - Boileau, C. AU - Borén, J. PY - 2015 DA - 2015// TI - Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment JO - Eur Heart J VL - 36 UR - https://doi.org/10.1093/eurheartj/ehv157 DO - 10.1093/eurheartj/ehv157 ID - Wiegman2015 ER - TY - JOUR AU - Cordova, C. M. AU - Schneider, C. R. AU - Juttel, I. D. AU - Cordova, M. M. PY - 2004 DA - 2004// TI - Comparison of LDL-cholesterol direct measurement with the estimate using the Friedewald formula in a sample of 10,664 patients JO - Arq Bras Cardiol VL - 83 UR - https://doi.org/10.1590/S0066-782X2004001800006 DO - 10.1590/S0066-782X2004001800006 ID - Cordova2004 ER - TY - JOUR AU - McNamara, J. R. AU - Cohn, J. S. AU - Wilson, P. W. AU - Schaefer, E. J. PY - 1990 DA - 1990// TI - Calculated values for low-density lipoprotein cholesterol in the assessment of lipid abnormalities and coronary disease risk JO - Clin Chem VL - 36 UR - https://doi.org/10.1093/clinchem/36.1.36 DO - 10.1093/clinchem/36.1.36 ID - McNamara1990 ER - TY - JOUR AU - Quispe, R. AU - Hendrani, A. AU - Elshazly, M. B. AU - Michos, E. D. AU - McEvoy, J. W. AU - Blaha, M. J. AU - Banach, M. AU - Kulkarni, K. R. AU - Toth, P. P. AU - Coresh, J. PY - 2017 DA - 2017// TI - Accuracy of low-density lipoprotein cholesterol estimation at very low levels JO - BMC Med VL - 15 UR - https://doi.org/10.1186/s12916-017-0852-2 DO - 10.1186/s12916-017-0852-2 ID - Quispe2017 ER - TY - JOUR AU - Palmer, M. K. AU - Barter, P. J. AU - Lundman, P. AU - Nicholls, S. J. AU - Toth, P. P. AU - Karlson, B. W. PY - 2019 DA - 2019// TI - Comparing a novel equation for calculating low-density lipoprotein cholesterol with the Friedewald equation: a VOYAGER analysis JO - Clin Biochem VL - 64 UR - https://doi.org/10.1016/j.clinbiochem.2018.10.011 DO - 10.1016/j.clinbiochem.2018.10.011 ID - Palmer2019 ER - TY - JOUR AU - Martin, S. S. AU - Giugliano, R. P. AU - Murphy, S. A. AU - Wasserman, S. M. AU - Stein, E. A. AU - Ceska, R. AU - Lopez-Miranda, J. AU - Georgiev, B. AU - Lorenzatti, A. J. AU - Tikkanen, M. J. PY - 2018 DA - 2018// TI - Comparison of low-density lipoprotein cholesterol assessment by Martin/Hopkins estimation, Friedewald estimation, and preparative ultracentrifugation: insights from the FOURIER trial JO - JAMA Cardiol VL - 3 UR - https://doi.org/10.1001/jamacardio.2018.1533 DO - 10.1001/jamacardio.2018.1533 ID - Martin2018 ER - TY - JOUR AU - Toth, P. P. AU - Granowitz, C. AU - Hull, M. AU - Anderson, A. AU - Philip, S. PY - 2019 DA - 2019// TI - Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis JO - Lipids Health Dis VL - 18 UR - https://doi.org/10.1186/s12944-019-1099-z DO - 10.1186/s12944-019-1099-z ID - Toth2019 ER - TY - JOUR AU - Rizos, C. V. AU - Barkas, F. AU - Elisaf, M. S. PY - 2014 DA - 2014// TI - Reaching low density lipoprotein cholesterol targets JO - Curr Med Res Opin VL - 30 UR - https://doi.org/10.1185/03007995.2014.941979 DO - 10.1185/03007995.2014.941979 ID - Rizos2014 ER - TY - JOUR AU - Langlois, M. R. AU - Nordestgaard, B. G. AU - Langsted, A. AU - Chapman, M. J. AU - Aakre, K. M. AU - Baum, H. AU - Boren, J. AU - Bruckert, E. AU - Catapano, A. AU - Cobbaert, C. PY - 2020 DA - 2020// TI - Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM JO - Clin Chem Lab Med VL - 58 UR - https://doi.org/10.1515/cclm-2019-1253 DO - 10.1515/cclm-2019-1253 ID - Langlois2020 ER - TY - JOUR AU - Nordestgaard, B. G. AU - Langsted, A. PY - 2016 DA - 2016// TI - Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology JO - J Lipid Res VL - 57 UR - https://doi.org/10.1194/jlr.R071233 DO - 10.1194/jlr.R071233 ID - Nordestgaard2016 ER - TY - JOUR AU - Saeedi, R. AU - Li, M. AU - Allard, M. AU - Frohlich, J. PY - 2014 DA - 2014// TI - Marked effects of extreme levels of lipoprotein(a) on estimation of low-density lipoprotein cholesterol JO - Clin Biochem VL - 47 UR - https://doi.org/10.1016/j.clinbiochem.2014.04.023 DO - 10.1016/j.clinbiochem.2014.04.023 ID - Saeedi2014 ER - TY - JOUR AU - Li, K. M. AU - Wilcken, D. E. AU - Dudman, N. P. PY - 1994 DA - 1994// TI - Effect of serum lipoprotein(a) on estimation of low-density lipoprotein cholesterol by the Friedewald formula JO - Clin Chem VL - 40 UR - https://doi.org/10.1093/clinchem/40.4.571 DO - 10.1093/clinchem/40.4.571 ID - Li1994 ER - TY - JOUR AU - Elisaf, M. AU - Bairaktari, H. AU - Siamopoulos, K. C. PY - 1996 DA - 1996// TI - Lp(a) levels in Greek patients with heterozygous familial hypercholesterolemia JO - Int J Cardiol VL - 53 UR - https://doi.org/10.1016/0167-5273(95)02542-1 DO - 10.1016/0167-5273(95)02542-1 ID - Elisaf1996 ER - TY - JOUR AU - Nordestgaard, B. G. AU - Chapman, M. J. AU - Ray, K. AU - Boren, J. AU - Andreotti, F. AU - Watts, G. F. AU - Ginsberg, H. AU - Amarenco, P. AU - Catapano, A. AU - Descamps, O. S. PY - 2010 DA - 2010// TI - Lipoprotein(a) as a cardiovascular risk factor: current status JO - Eur Heart J VL - 31 UR - https://doi.org/10.1093/eurheartj/ehq386 DO - 10.1093/eurheartj/ehq386 ID - Nordestgaard2010 ER - TY - JOUR AU - Saeedi, R. AU - Frohlich, J. PY - 2016 DA - 2016// TI - Lipoprotein (a), an independent cardiovascular risk marker JO - Clin Diabetes Endocrinol VL - 2 UR - https://doi.org/10.1186/s40842-016-0024-x DO - 10.1186/s40842-016-0024-x ID - Saeedi2016 ER - TY - JOUR AU - Cai, A. AU - Li, L. AU - Zhang, Y. AU - Mo, Y. AU - Mai, W. AU - Zhou, Y. PY - 2013 DA - 2013// TI - Lipoprotein(a): a promising marker for residual cardiovascular risk assessment JO - Dis Markers VL - 35 UR - https://doi.org/10.1155/2013/563717 DO - 10.1155/2013/563717 ID - Cai2013 ER - TY - JOUR AU - Kouvari, M. AU - Panagiotakos, D. B. PY - 2019 DA - 2019// TI - The role of lipoprotein (a) in primary and secondary cardiovascular disease prevention: a systematic review of epidemiological studies JO - Curr Opin Cardiol VL - 34 UR - https://doi.org/10.1097/HCO.0000000000000628 DO - 10.1097/HCO.0000000000000628 ID - Kouvari2019 ER - TY - JOUR AU - Langsted, A. AU - Kamstrup, P. R. AU - Benn, M. AU - Tybjaerg-Hansen, A. AU - Nordestgaard, B. G. PY - 2016 DA - 2016// TI - High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study JO - Lancet Diabetes Endocrinol VL - 4 UR - https://doi.org/10.1016/S2213-8587(16)30042-0 DO - 10.1016/S2213-8587(16)30042-0 ID - Langsted2016 ER - TY - STD TI - Tsimikas S, Gordts P, Nora C, Yeang C, Witztum JL. Statin therapy increases lipoprotein(a) levels. Eur Heart J. 2019; [Epub ahead of print]. ID - ref42 ER - TY - JOUR AU - Wissen, S. AU - Smilde, T. J. AU - Trip, M. D. AU - Boo, T. AU - Kastelein, J. J. AU - Stalenhoef, A. F. PY - 2003 DA - 2003// TI - Long term statin treatment reduces lipoprotein(a) concentrations in heterozygous familial hypercholesterolaemia JO - Heart VL - 89 UR - https://doi.org/10.1136/heart.89.8.893 DO - 10.1136/heart.89.8.893 ID - Wissen2003 ER - TY - JOUR AU - Willeit, P. AU - Ridker, P. M. AU - Nestel, P. J. AU - Simes, J. AU - Tonkin, A. M. AU - Pedersen, T. R. AU - Schwartz, G. G. AU - Olsson, A. G. AU - Colhoun, H. M. AU - Kronenberg, F. PY - 2018 DA - 2018// TI - Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials JO - Lancet VL - 392 UR - https://doi.org/10.1016/S0140-6736(18)31652-0 DO - 10.1016/S0140-6736(18)31652-0 ID - Willeit2018 ER - TY - JOUR AU - Banach, M. AU - Penson, P. E. PY - 2020 DA - 2020// TI - Statins and Lp(a): do not make perfect the enemy of excellent JO - Eur Heart J VL - 41 UR - https://doi.org/10.1093/eurheartj/ehz927 DO - 10.1093/eurheartj/ehz927 ID - Banach2020 ER - TY - JOUR AU - O'Donoghue, M. L. AU - Fazio, S. AU - Giugliano, R. P. AU - Stroes, E. S. G. AU - Kanevsky, E. AU - Gouni-Berthold, I. AU - Im, K. AU - Lira Pineda, A. AU - Wasserman, S. M. AU - Ceska, R. PY - 2019 DA - 2019// TI - Lipoprotein(a), PCSK9 inhibition, and cardiovascular risk JO - Circulation VL - 139 UR - https://doi.org/10.1161/CIRCULATIONAHA.118.037184 DO - 10.1161/CIRCULATIONAHA.118.037184 ID - O'Donoghue2019 ER - TY - STD TI - Liberopoulos E. Lipoprotein(a) reduction with PCSK9 inhibitors: an unsolved mystery. Eur J Prev Cardiol. 2020; [Epub ahead of print]. ID - ref47 ER - TY - JOUR AU - Ray, K. K. AU - Vallejo-Vaz, A. J. AU - Ginsberg, H. N. AU - Davidson, M. H. AU - Louie, M. J. AU - Bujas-Bobanovic, M. AU - Minini, P. AU - Eckel, R. H. AU - Cannon, C. P. PY - 2019 DA - 2019// TI - Lipoprotein(a) reductions from PCSK9 inhibition and major adverse cardiovascular events: pooled analysis of alirocumab phase 3 trials JO - Atherosclerosis VL - 288 UR - https://doi.org/10.1016/j.atherosclerosis.2019.06.896 DO - 10.1016/j.atherosclerosis.2019.06.896 ID - Ray2019 ER - TY - JOUR AU - Bittner, V. A. AU - Szarek, M. AU - Aylward, P. E. AU - Bhatt, D. L. AU - Diaz, R. AU - Edelberg, J. M. AU - Fras, Z. AU - Goodman, S. G. AU - Halvorsen, S. AU - Hanotin, C. PY - 2020 DA - 2020// TI - Effect of Alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome JO - J Am Coll Cardiol VL - 75 UR - https://doi.org/10.1016/j.jacc.2019.10.057 DO - 10.1016/j.jacc.2019.10.057 ID - Bittner2020 ER -